Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
Clinical trial NCT00801385 · UNKNOWN
Trial details
- NCT number
- NCT00801385
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-06-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.